Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- Status
- RECRUITING
- Phase
- N/A
The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
- Status
- RECRUITING
- Phase
- PHASE2
Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE3
A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2
NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- Status
- RECRUITING
- Phase
- PHASE3
Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT
- Status
- RECRUITING
- Phase
- PHASE2
A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL
- Status
- UNKNOWN
- Phase
- PHASE2